Characteristics | Groups | P | |
---|---|---|---|
Non-prolonged MV (n = 30) | Prolonged MV (n = 26) | ||
Gender Males n (%) | 23 (76.67%) | 22 (84.62%) | 0.455 |
Age (years) | 49.90 ± 16.60 | 54.27 ± 16.52 | 0.329 |
SOFA | 11.09 ± 2.01 | 12.56 ± 2.71 | 0.003 |
MV (hours) | 97.33 ± 26.97 | 280.50 ± 141.65 | < 0.001 |
ICU LOS (days) | 8.13 ± 4.14 | 15.73 ± 7.02 | <0.001 |
Types of surgery | |||
 CABG n (%) | 6 (20.00%) | 5 (19.23%) | 0.942 |
 Pericardiectomy n (%) | 10 (33.33%) | 13 (50.00%) | 0.206 |
 Valve surgery n (%) | 13 (43.33%) | 9 (34.62%) | 0.505 |
 Ventricular septal defect repair n (%) | 0 (00.00%) | 1 (3.85%) | 0.464 |
 Atrial neoplasms resection n (%) | 2 (6.67%) | 0 (0.00%) | 0.282 |
 Replacement of aorta n (%) | 1 (3.33%) | 0 (0.00%) | 1.000 |
ECC duration (min) | 116.21 ± 98.56 | 82.56 ± 79.50 | 0.200 |
Concomitant diseases | |||
 Hypertension n (%) | 11 (36.67%) | 6 (23.08%) | 0.270 |
 Diabetes n (%) | 7 (23.33%) | 3 (11.54%) | 0.310 |
 CAC n (%) | 8 (26.67%) | 5 (19.23%) | 0.511 |
 CKD n (%) | 4 (13.33%) | 1 (3.85%) | 0.358 |
 CHF n (%) | 8 (26.67%) | 9 (34.62%) | 0.519 |
Post-surgery drugs | |||
 Vasopressors | |||
  0-24 h n (%) | 28 (93.33%) | 26 (100%) | 0.494 |
  24-48 h n (%) | 25 (83.33%) | 26 (100%) | 0.055 |
   > 48 h n (%) | 24 (80.00%) | 26 (100%) | < 0.001 |
 Intropes | |||
  0-24 h n (%) | 28 (93.33%) | 25 (96.15%) | 1.000 |
  24-48 h n (%) | 28 (93.33%) | 25 (96.15%) | 1.000 |
   > 48 h n (%) | 19 (63.33%) | 20 (76.92%) | 0.384 |